Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe. (2021)

First Author: Noguera-Julian A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.01196-2021

PubMed Identifier: 34049946

Publication URI: http://europepmc.org/abstract/MED/34049946

Type: Journal Article/Review

Volume: 58

Parent Publication: The European respiratory journal

Issue: 3

ISSN: 0903-1936